# Clinical Study of in Situ Regeneration of Endometrium

> **NCT04233892** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Yali Hu** · enrollment: 345 (estimated)

## Conditions studied

- Infertility, Female, of Uterine Origin
- Endometrial Fibrosis

## Interventions

- **DRUG:** CBD-bFGF
- **DRUG:** Collagen/BMMNCs
- **DRUG:** Estrogen

## Key facts

- **NCT ID:** NCT04233892
- **Lead sponsor:** Yali Hu
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-29
- **Primary completion:** 2022-12
- **Final completion:** 2024-12
- **Target enrollment:** 345 (ESTIMATED)
- **Last updated:** 2022-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04233892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04233892, "Clinical Study of in Situ Regeneration of Endometrium". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04233892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*